Opexa Therapeutics Inc. (NASDAQ:OPXA) & Dell Inc. (NASDAQ:DELL) Are Big Gainers - OPXA, DELL, MCD, ADM, WAG

Lakeway, TX -- (SBWIRE) -- 02/05/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Opexa Therapeutics Inc. (NASDAQ:OPXA) shares soared 294.91% to $4.62 in the morning hour after the company today announced the execution of an agreement with Merck Serono, a division of Merck, Darmstadt, Germany, for the development and commercialization of Tcelna (imilecleucel-T), a potential personalized T-cell therapy for patients suffering from multiple sclerosis. Tcelna (imilecleucel-T) is being developed by Opexa and is in a Phase IIb clinical trial in patients with Secondary Progressive MS (SPMS). Potential payments to Opexa from the option and license agreement could total $225 million based upon the development and commercialization of Tcelna for MS.

Should Investors Buy OPXA After The Recent Plunge? Find Out Here

Dell Inc. (NASDAQ:DELL) stock is trading at $13.27. Dell is selling itself for $24.4 billion to its founder and a group of investors that includes Microsoft. It’s the largest deal of its kind since the Great Recession dried up financing for risky maneuvers like this. The complex agreement announced today will end Dell Inc.’s nearly 25-year history as a publicly traded company. Shareholders are receiving $13.65 per share for their stock.

We Have A Free Trend Analysis on DELL, Find Out Here

McDonald's Corporation (NYSE:MCD) stock gained 0.26% to $94.82. The company yesterday said it is offering its new Fish McBites as a Happy Meal entree for kids. The Oak Brook-based hamburger chain, has been testing the Fish McBites in select markets but launched the new menu item nationwide this month. It will be available through March, to coincide with Lent.

Get More latest News, Rumors and Updates On MCD Here

Archer Daniels Midland Company (NYSE:ADM) shares climbed 1.97% to $29 in the early hour after the company today reported second-quarter net earnings of $510 million, or $0.77 per share, from $80 million or $0.12 per share in the same period one year earlier. Adjusted earnings per share for the quarter were $0.60, up from $0.51 in the same period last year. Analysts expected the company to report earnings of $0.58 per share for the quarter. Net sales and other operating income for the quarter rose to $24.92 billion from $23.31 billion in the prior year quarter. Analysts had consensus revenue estimate of $23.67 billion for the quarter.

How To Trade ADM Now After The Recent Volatile Moves? Find Out Here

Walgreen Company (NYSE:WAG) shares climbed 1.52% to $40.62 in the morning hour after the company today posted its first monthly same-store sales gain in a year in January. The 3.7% increase in same-store sales in January came above the projected 1.5% increase. Overall, total sales in January grew 6.3% to $6.15 billion from a year ago. Front-end sales were up 1.3%, while same- store front-end sales slid 0.4%, compared with expectations of a 0.5% drop.

Don’t Forget To Get Your Free Trend Analysis Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.